Sep 16, 2020 // Cell
T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity
Finding may help explain why people 65 and above face a higher risk of falling critically ill with COVID-19
Aug 27, 2020 // Immunity
Beating HIV and COVID-19 may depend on tweaking vaccine molecules
LJI and Scripps Research scientists tackle the problem of antigen valency
Aug 20, 2020
LJI Professor Erica Ollmann Saphire awarded $6.4 million for international efforts to beat COVID-19
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded more than $6.4 million to Dr. Saphire to support research toward COVID-19 antibody therapeutics.
Aug 18, 2020 // Cell
LJI team gets first-ever look at a rare but vital stem cell in humans
New understanding of immune cell origins may offer cancer and COVID-19 drug targets
Aug 8, 2020 // The Washington Post
Forty percent of people with coronavirus infections have no symptoms. Might they be the key to ending the pandemic?
New research suggests that some of us may be partially protected due to past encounters with common cold coronaviruses